Showing results (201-210 of 323) with videos related to

Sort By:
Pageof 33
JAMA Oncology|August 15, 2024
Lazertinib in EGFR-Variant Non-Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors: A Nonrandomized Controlled TrialMin Hee Hong, Yoon Ji Choi, Hee Kyung Ahn, et al.
Annals of Palliative Medicine|April 3, 2020
Symptom burden and characteristics of patients who die in the acute palliative care unit of a tertiary cancer centerGrace S Ahn, Hak Ro Kim, Beodeul Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2025
Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 TrialCharles M Rudin, Melissa L Johnson, Luis Paz-Ares, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2019
Association of illness understanding with advance care planning and end-of-life care preferences for advanced cancer patients and their family membersShin Hye Yoo, Jihye Lee, Jung Hun Kang, et al.
American Journal of Clinical Pathology|November 13, 2014
HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancerHee Jin Lee, An Na Seo, Eun Joo Kim, et al.
Plos One|May 13, 2024
SupporTive Care At Home Research (STAHR) for patients with advanced cancer: Protocol for a cluster non-randomized controlled trialDong-Wook Lee, Sun Young Lee, Shin Hye Yoo, et al.
Anticancer Research|September 27, 2015
Salvage Treatment with Intracerebrospinal Fluid Thiotepa in Patients with Leptomeningeal Metastasis After Failure of Methotrexate-based TreatmentKyoung-Min Cho, Yu Jung Kim, Se Hyun Kim, et al.
BMC Cancer|August 11, 2012
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancerMi-Jung Kim, Hye Seung Lee, Jee Hyun Kim, et al.
Cancer Chemotherapy and Pharmacology|April 11, 2015
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancerJin Won Kim, In Sil Choi, Yu Jung Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 26, 2012
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survivalEun Joo Kang, Seock-Ah Im, Do-Youn Oh, et al.
Pageof 33